News Analysis: Getting Polio Campaigns Back on Track





How in the world did something as innocuous as the sugary pink polio vaccine turn into a flash point between Islamic militants and Western “crusaders,” flaring into a confrontation so ugly that teenage girls — whose only “offense” is that they are protecting children — are gunned down in the streets?




Nine vaccine workers were killed in Pakistan last week in a terrorist campaign that brought the work of 225,000 vaccinators to a standstill. Suspicion fell immediately on factions of the Pakistani Taliban that have threatened vaccinators in the past, accusing them of being American spies.


Polio eradication officials have promised to regroup and try again. But first they must persuade the killers to stop shooting workers and even guarantee safe passage.


That has been done before, notably in Afghanistan in 2007, when Mullah Muhammad Omar, spiritual head of the Afghan Taliban, signed a letter of protection for vaccination teams. But in Pakistan, the killers may be breakaway groups following no one’s rules.


Vaccination efforts are also under threat in other Muslim regions, although not this violently yet.


In Nigeria, another polio-endemic country, the new Islamic militant group Boko Haram has publicly opposed it, although the only killings that the news media have linked to polio were those of two police officers escorting vaccine workers. Boko Haram has killed police officers on other missions, unrelated to polio vaccinations.


In Mali, extremists took over half of the country in May, declaring an Islamic state. Vaccination is not an issue yet, but Mali had polio cases as recently as mid-2011, and the virus sometimes circulates undetected.


Resistance to polio vaccine springs from a combination of fear, often in marginalized ethnic groups, and brutal historical facts that make that fear seem justified. Unless it is countered, and quickly, the backlash threatens the effort to eradicate polio in the three countries where it remains endemic: Pakistan, Afghanistan and Nigeria.


In 1988, long before donors began delivering mosquito nets, measles shots, AIDS pills, condoms, deworming drugs and other Western medical goods to the world’s most remote villages, Rotary International dedicated itself to wiping out polio, and trained teams to deliver the vaccine.


But remote villages are often ruled by chiefs or warlords who are suspicious not only of Western modernity, but of their own governments.


The Nigerian government is currently dominated by Christian Yorubas. More than a decade ago, when word came from the capital that all children must swallow pink drops to protect them against paralysis, Muslim Hausas in the far-off north could be forgiven for reacting the way the fundamentalist Americans of the John Birch Society did in the 1960s when the government in far-off Washington decreed that, for the sake of children’s teeth, all drinking water should have fluoride.


The northerners already had grievances. In 1996, the drug company Pfizer tested its new antibiotic, Trovan, during a meningitis outbreak there. Eleven children died. Although Pfizer still says it was not to blame, the trial had irregularities, and last year the company began making payments to victims.


Other rumors also spring from real events.


In Pakistan, resistance to vaccination, low over all, is concentrated in Pashtun territory along the Afghan border and in Pashtun slums in large cities. Pashtuns are the dominant tribe in Afghanistan but a minority in Pakistan among Punjabis, Sindhis, Baluchis and other ethnic groups. Many are Afghan refugees and are often poor and dismissed as medieval and lawless.


Pakistan’s government is friendly with the United States while the Pashtuns’ territory in border areas has been heavily hit by American Taliban-hunting drones, which sometimes kill whole families.


So, when the Central Intelligence Agency admitted sponsoring a hepatitis vaccination campaign as a ruse to get into a compound in Pakistan to confirm that Osama bin Laden was there, and the White House said it had contemplated wiping out the residence with a drone missile, it was not far-fetched for Taliban leaders to assume that other vaccinators worked for the drone pilots.


Even in friendly areas, the vaccine teams have protocols that look plenty suspicious. If a stranger knocked on a door in Brooklyn, asked how many children under age 5 were at home, offered to medicate them, and then scribbled in chalk on the door how many had accepted and how many refused — well, a parent might worry.


In modern medical surveys — though not necessarily on polio campaigns — teams carry GPS devices so they can find houses again. Drones use GPS coordinates.


The warlords of Waziristan made the connection specific, barring all vaccination there until Predator drones disappeared from the skies.


Dr. Bruce Aylward, a Canadian who is chief of polio eradication for the World Health Organization, expressed his frustration at the time, saying, “They know we don’t have any control over drone strikes.”


The campaign went on elsewhere in Pakistan — until last week.


The fight against polio has been hampered by rumors that the vaccine contains pork or the virus that causes AIDS, or is a plot to sterilize Muslim girls. Even the craziest-sounding rumors have roots in reality.


The AIDS rumor is a direct descendant of Edward Hooper’s 1999 book, “The River,” which posited the theory — since discredited — that H.I.V. emerged when an early polio vaccine supposedly grown in chimpanzee kidney cells contaminated with the simian immunodeficiency virus was tested in the Belgian Congo.


The sterilization claim was allegedly first made on a Nigerian radio station by a Muslim doctor upset that he had been passed over for a government job. The “proof” was supposed to be lab tests showing it contained estrogen, a birth control hormone.


The vaccine virus is grown in a broth of live cells; fetal calf cells are typical. They may be treated with a minute amount of a digestive enzyme, trypsin — one source of which is pig pancreas, which could account for the pork rumor.


In theory, a polio eradicator explained, if a good enough lab tested the vaccine used at the time the rumor started, it might have detected estrogen from the calf’s mother, but it would have been far less estrogen than is in mother’s milk, which is not accused of sterilizing anyone. The trypsin is supposed to be washed out.


In any case, polio vaccine is now bought only from Muslim countries like Indonesia, and Muslim scholars have ruled it halal — the Islamic equivalent of kosher.


Reviving the campaign will mean quelling many rumors. It may also require adding other medical “inducements,” like deworming medicine, mosquito nets or vitamin A, whose immediate benefits are usually more obvious.


But changing mind-sets will be a crucial step, said Dr. Aylward, who likened the shootings of the girls to those of the schoolchildren in Newtown, Conn.


More police involvement — what he called a “bunkerized approach” — would not solve either America’s problem or Pakistan’s, he argued. Instead, average citizens in both countries needed to rise up, reject the twisted thinking of the killers and “generate an understanding in the community that this kind of behavior is not acceptable.”


Read More..

Russia Opens 3rd Investigation on Protest Leader







MOSCOW (Reuters) - Russian authorities have opened a third criminal investigation into opposition leader Alexei Navalny, saying on Monday that the critic of President Vladimir Putin is suspected of stealing millions of dollars from a political party in 2007.




Navalny, 36, the most prominent leader of large street protests that erupted last December against Putin's nearly 13-year rule, already faces up to 10 years in jail if convicted on existing charges of theft from a state timber company.


Earlier this month, investigators also charged Navalny and his brother of cheating a mail-transport company out of $1.79 million. That move followed a December15 opposition rally at a memorial to victims of Soviet-era repressions outside the headquarters of the FSB security service, formerly the KGB.


Navalny, a lawyer and anti-corruption blogger, denies any wrongdoing and says the accusations aired by the Investigative Committee, a federal agency that answers to Putin, are intended to persuade him to stop his opposition activities.


"Aie, aie, aie, yet another case against me. Investigative Committee, what are you doing? ... That's enough," Navalny tweeted minutes after the new investigation was announced.


The Interfax news agency quoted him as saying the charge was "absolutely absurd".


On its website, the Investigative Committee said it suspects an advertising company headed by Navalny stole up to 100 million roubles ($3.24 million) paid it by the liberal, pro-business Union of Right Forces Party (SPS) for campaign advertising.


It said there was evidence Navalny's company, Allekt, siphoned the money off into bank accounts of shell companies.


A former SPS party leader, Leonid Gozman, dismissed the charges as nonsense and said the party had no accusations or complaints against Navalny, Interfax reported.


Navalny said the fact that investigators had initiated the case without a complaint from the party showed that it was politically motivated, and he vowed not to give up his activism, Interfax reported.


The Investigative Committee said it had encountered the evidence related to SPS while investigating its case against Navalny on the timber theft charge.


Navalny is a key leader of an opposition council, elected in an online vote in October, that is trying maintain the momentum of a protest movement that drew crowds of up to 100,000 people onto Moscow's streets at its peak last winter, but failed to prevent Putin winning a six-year third term as president.


Since then, pro-Kremlin lawmakers have passed a series of laws that the opposition say are intended to stifle dissent. Several opposition leaders and dozens of activists are facing criminal charges or investigation.


(Reporting By Alissa de Carbonnel; Editing by Steve Gutterman and Jon Boyle)


Read More..

Saudi website editor could face death for apostasy-rights group






RIYADH (Reuters) – The editor of a Saudi Arabian website could be sentenced to death after a judge cited him for apostasy and moved his case to a higher court, the monitoring group Human Rights Watch said on Saturday.


Raif Badawi, who started the Free Saudi Liberals website to discuss the role of religion in Saudi Arabia, was arrested in June, Human Rights Watch said.






Badawi had initially been charged with the less serious offence of insulting Islam through electronic channels, but at a December 17 hearing a judge referred him to a more senior court and recommended he be tried for apostasy, the monitoring group said.


Apostasy, the act of changing religious affiliation, carries an automatic death sentence in Saudi Arabia, along with crimes including blasphemy.


Badawi’s website included articles that were critical of senior religious figures, the monitoring group said.


A spokesman for Saudi Arabia’s Justice Ministry was not available to comment.


The world’s top oil exporter follows the strict Wahhabi school of Islam and applies Islamic law, or sharia.


Judges base their decisions on their own interpretation of religious law rather than on a written legal code or on precedent.


King Abdullah, Saudi Arabia’s ruler, has pushed for reforms to the legal system, including improved training for judges and the introduction of precedent to standardize verdicts and make courts more transparent.


However, Saudi lawyers say that conservatives in the Justice Ministry and the judiciary have resisted implementing many of the changes that he announced in 2007. (Reporting By Angus McDowall; Editing by Kevin Liffey)


Internet News Headlines – Yahoo! News





Title Post: Saudi website editor could face death for apostasy-rights group
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

A huge collection of odd TV stuff needs a home


LOS ANGELES (AP) — James Comisar is the first to acknowledge that more than a few have questioned his sanity for spending the better part of 25 years collecting everything from the costume George Reeves wore in the 1950s TV show "Superman" to the entire set of "The Tonight Show Starring Johnny Carson."


Then there's the pointy Spock ears Leonard Nimoy wore on "Star Trek" and the guns Tony Soprano used to rub out a mob rival in an episode of "The Sopranos."


"Along the way people thought I was nuts in general for wanting to conserve Keith Partridge's flared pants from 'The Partridge Family,'" the good-natured former TV writer says of the 1970s sitcom as he ambles through rows of costumes, props and what have you from the beginnings of television to the present day.


"But they really thought I needed a psychological workup," Comisar, 48, adds with a smile, "when they learned I was having museum curators take care of these pieces."


A museum is exactly where he wants to put all 10,000 of his TV memorabilia items, everything from the hairpiece Carl Reiner wore on the 1950s TV variety program "Your Show of Shows" to the gun and badge Kiefer Sutherland flashed on "24" a couple TV seasons ago.


Finding one that could accommodate his collection, which fills two sprawling, temperature-controlled warehouses, however, has sometimes been as hard as acquiring the boots Larry Hagman used to stomp around in when he was J.R. on "Dallas." (The show's production company finally coughed up a pair after plenty of pleading and cajoling.)


Comisar is one of many people who, after a lifetime of collecting, begin to realize that if they can't find a permanent home for their artifacts those objects could easily end up on the trash heap of history. Or, just as bad as far as he's concerned, in the hands of private collectors.


"Some of the biggest bidders for Hollywood memorabilia right now reside in mainland China and Dubai, and our history could leave this country forever," says Comisar, who these days works as a broker and purchasing expert for memorabilia collectors.


What began as a TV-obsessed kid's lark morphed into a full-fledged hobby when as a young man writing jokes for Howie Mandel and Joan Rivers, and punching up scripts for such producers as Norman Lear and Fred Silverman, Comisar began scouring studio back lots, looking for discarded stuff from the favorite shows of his childhood. From there it developed into a full-on obsession, dedicated to preserving the entire physical spectrum of television history.


"After a couple years of collecting, it became clear to me," he says, "that it didn't much matter what TV shows James watched in the early 1970s but which shows were the most iconic. In that way, I had sort of a curator's perspective almost from the beginning."


In the early days, collecting such stuff was easy for anyone with access to a studio back lot. Many items were simply thrown out or given away when shows ceased production. When studios did keep things they often rented them out for small fees, and if you lost or broke them you paid a small replacement fee. So Comisar began renting stuff right and left and promptly losing it, acquiring one of Herman Munster's jackets that way.


These days almost everything has a price, although Comisar's reputation as a serious collector has led some people to give him their stuff.


If he simply sold it all, he could probably retire as a millionaire several times over. Just last month someone paid $480,000 for a faded dress Judy Garland wore in the 1939 film "The Wizard of Oz." What might Annette Funicello's original Mickey Mouse Club jacket fetch?


He won't even think about that.


"I've spent 25 years now reuniting these pieces, and I would be so sick if some day they were just broken up and sold to the highest bidder," he says.


He, and every other serious collector of cool but somewhat oddball stuff, face two major obstacles, say museum curators: Finding a museum or university with the space to take their treasures and persuading deep-pocketed individuals who might bankroll the endeavor that there's really any compelling reason to preserve something like Maxwell Smart's shoephone.


"People hold television and popular culture so close to their hearts and embrace it so passionately," says Dwight Bowers, curator of entertainment collections for the Smithsonian's National Museum of American History, who calls Comisar's collection very impressive. "But they don't put it on the same platform as military history or political history."


When the Smithsonian acquired Archie Bunker's chair from the seminal TV comedy "All in the Family," Bowers said, museum officials took plenty of flak from those offended that some sitcom prop was being placed down the hallway from the nation's presidential artifacts.


The University of California, Santa Cruz, took similar heat when it accepted the Grateful Dead archives, 30 years of recordings, videos, papers, posters and other memorabilia gifted by the band, said university archivist Nicholas Meriwether.


"What I always graciously say is that if you leave the art and the music aside for one moment, whatever you think of it, what you can say is they are still a huge part of understanding the story of the 1960s and of understanding the nation's counterculture," says Meriwether.


Comisar sees his television collection serving the same purpose, tracing societal changes TV shows documented from the post-World War II years to the present.


The Academy of Television Arts and Sciences Foundation looked into establishing such a museum some years back, and Comisar's collection came up at the time, said Karen Herman, curator of the foundation's Archive of American Television.


Instead, the foundation settled on an online archive containing more than 3,000 hours of filmed oral history interviews with more than 700 people.


While the archive doesn't have any of Mr. Spock's ears, anyone with a computer can view and listen to an oral history from Spock himself, the actor Leonard Nimoy.


Comisar, meanwhile, believes he's finally found the right site for a museum, in Phoenix, where he's been lining up supporters. He estimates it will cost $35 million and several years to open the doors, but hopes to have a preview center in place by next year.


Mo Stein, a prominent architect who heads the Phoenix Community Alliance and is working with him, says one of the next steps will be finding a proper space for the collection.


But, really, why all the fuss over a place to save one of the suits Regis Philbin wore on "Who Wants to be a Millionaire"?


"In Shakespeare's time, his work was considered pretty low art," Comisar responds.


Oh, he'll admit that "Mike and Molly," the modern TV love story of a couple who fall for each other at Overeaters Anonymous, may never rank in the same category as "Romeo and Juliet."


"But what about a show like 'Star Trek'?" he asks.


Read More..

The New Old Age Blog: Fudging the Facts, for Peace of Mind

Lou, my beloved grandfather, lived almost 101 years and obsessively worried every single day of his adult life — probably because his adult life began before it should have. As a child in Russia, he watched helplessly as his mother and sister were killed during a vicious pogrom in their village.

Lou (I called him Zadie) made his way to America, and immediately began imagining the worst about his fate, and his family’s fate, in his new country. I believe Zadie lived as long as he did because he was afraid of what would happen to his children, grandchildren, and great-grandchildren if he wasn’t here to protect them.

When I was a third-year medical student in New York City, he called from Denver very early one morning, waking me and my roommates. He had been listening to his transistor radio on one of his many sleepless nights of worry, and had heard that a Staten Island Ferry boat had crashed, injuring numerous passengers.

There were more than seven million people in the city, and Zadie called at 4 a.m. to make sure I wasn’t one of those injured. It was from him we learned the importance of telling white lies and omitting certain truths with our elderly parents and grandparents.

Before accusing me of infantilizing and patronizing my older family members, hear me out. Anxiety disorders can be debilitating for the elderly. A comprehensive review of the subject found 10 to14 percent of those 65 and older meet the criteria for these diagnoses, a significantly higher figure than for the more widely recognized depression syndromes in the same demographic.

Indeed, depression and anxiety disorders often occur together. Anxiety disorders are underdiagnosed in the elderly, largely because the symptoms are often assumed to be just another manifestation of aging. Additionally, the clinical assessment of the elderly for anxiety is more complicated than for younger patients because the signs may differ from those classically described in the diagnostic manuals.

A large national study showed an increased incidence of general anxiety disorder beginning after age 55, and the National Alliance on Mental Illness notes that, like depression, obsessive-compulsive disorder tends to worsen in old age. Factors contributing to the prevalence and severity of anxiety disorders in the elderly include a host of concomitant medical problems that interact with anxiety in a complicated way.

From the review article cited earlier:

The co-morbidity between medical illness and anxiety disorders poses difficulties for…diagnosis and detection of anxiety. Researchers have suggested that older adults may be more likely to attribute physical symptoms related to anxiety to medical issues… In turn, many physical conditions, such as cardiovascular disease, respiratory disease, hyperthyroidism, and pulmonary and vestibular difficulties, can mimic the symptoms of anxiety…making it difficult to establish the underlying cause…

Furthermore, the symptoms that result from medical illnesses may produce fearful bodily sensations that may result in the subsequent development of anxiety disorders.

As an example, more than 40 percent of patients with Parkinson’s disease meet the criteria for an anxiety disorder. Dementia is also associated with anxiety in a bidirectional way — anxiety can accelerate cognitive decline, which in turn can increase symptoms of anxiety. Added to this morass are the side effects, which can include anxiety, of many medications taken by older patients.

The elderly clearly are an at-risk population for anxiety disorders. Which brings us back to white lies. Zadie’s well-earned anxieties, obsessions and worries accelerated greatly as he got older, and we realized they could largely be prevented if we simply didn’t share the complete truth with him all the time. This became known in our family as the Zadie Filter.

When we took our children to the mountains, we told him we were headed to Colorado Springs; he’d been to Colorado Springs many times and knew it was a flat highway drive from Denver. No high mountain passes or narrow roads without guardrails.

When he begged my sons to become doctors so they would serve behind the front lines in the event they were drafted (this was long after the military draft ended, which was still not reassuring enough for Zadie), they so promised. When our daughter started driving, Zadie warned her it wasn’t safe for a girl to drive alone in case she had car trouble; she promised she would always have company in the car.

Zadie died when his great-grandchildren were still teenagers, and so he never had to know that the boys didn’t go into medicine and that his great-granddaughter drives alone.

My mother, Zadie’s daughter, inherited his anxieties, and as she has entered her mid-80s her symptoms have also markedly increased. On the other side of the family, my mother-in-law’s issues with anxiety began with her Parkinson’s disease and have worsened as her neurological condition has progressed.

With our mothers, we also rely on the Zadie Filter. Our white lies and omissions reduce their worries — which is not to say we can protect them from all triggers (they still read the newspaper and watch the nightly news), but even a bit of relief for them is relief for us as well.

Our parents live for the most part on fixed incomes, so when we’re able to cover some of their expenses without their knowing, we do so, and they worry a little less about their bills. All it takes is a little white lie: “The apartment manager waived your heating bill this month because you’ve been such a good long-term tenant,” or, “Of course I used your credit card when I paid for your medicines.”

My mother accidentally found out that our son broke his finger (playing flag football during finals week!) when a well-intentioned friend asked her how her grandson was doing after his injury. She was upset we hadn’t told her — but only for a few moments, until we explained that it had happened a week before, that he was all splinted up and was in no pain. All of which was 100 percent true, and she didn’t lose a minute of sleep worrying about it.

Last week, after pressing our law student son (he of the broken finger) about a school transcript issue I’ve been worried about for him, he assured me it had been taken care of. Our daughter in grad school goes into bars only when she’s with a large group of friends, and our college son is the designated driver for all of his fraternity functions.

And so it begins.


Dr. Harley A. Rotbart is professor and vice chairman of pediatrics at the University of Colorado School of Medicine and the author of “No Regrets Parenting.”

Read More..

Gun Makers Based in Connecticut Form a Potent Lobby





Gun owners packed a hearing room in the Connecticut capital, vowing to oppose a bill that would require new markers on guns so that they are easier to trace.




One after another, they testified that the technology, called microstamping, was flawed and would increase the cost of guns.


But the witness who commanded the most attention in Hartford that day in 2009 was a representative of one of Connecticut’s major employers: the Colt Manufacturing Company, the gun maker.


The Colt executive, Carlton S. Chen, said the company would seriously consider leaving the state if the bill became law. “You would think that the Connecticut government would be in support of our industry,” Mr. Chen said.


Soon, Connecticut lawmakers shelved the bill; they have declined to take it up since. Now, in the aftermath of the school massacre in Newtown, the lawmakers are formulating new gun-control measures, saying the state must serve as a national model.


But the failed effort to enact the microstamping measure shows how difficult the climate has been for gun control in state capitals. The firearm companies have played an important role in defeating these measures by repeatedly warning that they will close factories and move jobs if new state regulations are approved.


The companies have issued such threats in several states, especially in the Northeast, where gun control is more popular. But their views have particular resonance in Connecticut, a cradle of the American gun industry.


Like manufacturing in Connecticut over all, the state’s gun industry is not as robust as it once was. Still, Connecticut remains the seventh-largest producer of firearms in the country, according to federal data.


Colt, based in Connecticut since the 1800s, employs roughly 900 people in the state. Two other major gun companies, Sturm, Ruger & Company and Mossberg & Sons, are also based in the state. In all, the industry employs about 2,000 people in Connecticut, company officials said.


Gun-control advocates have long viewed Hartford, the capital, as hospitable terrain, because Connecticut is a relatively liberal state and already has more gun restrictions than most. Democrats control both houses of the legislature.


Yet lawmakers in Hartford did more than shelve the microstamping bill in 2009. They also declined to push a bill last year that would have banned high-capacity ammunition magazines — the very accessory used by Adam Lanza to kill 26 people, including 20 children, at Sandy Hook Elementary School in Newtown.


In several states, the gun companies have enlisted unions that represent gun workers, mindful that Democratic lawmakers who might otherwise back gun control also have close ties to labor.


In Connecticut, the United Automobile Workers, which represents Colt workers, has testified against restrictions. The union’s arguments were bolstered last year when Marlin Firearms, a leading manufacturer of rifles, closed a factory in Connecticut that employed more than 200 people. Marlin cited economic pressures, not gun regulation, for the decision, but representatives of the gun industry have said the combination of the two factors could spur others to move.


State law significantly restricts the ability of corporations to make political donations in Connecticut. Employees of Connecticut gun companies have contributed several thousand dollars in total in recent years to state candidates, mostly Republicans, according to an analysis of state records.


Financially, the gun companies and their employees in Connecticut have exerted influence by donating to national groups, especially the National Rifle Association, which have in turn helped Connecticut gun rights groups, according to interviews and financial records.


But it appears that in Hartford, the companies are relying largely on economic arguments.


Their strategy has been led by the industry’s trade group, the National Shooting Sports Foundation, which happens to have its national headquarters in Newtown, a few miles from the site of the shootings.


When Connecticut lawmakers held a hearing in 2011 on the measure to ban high-capacity ammunition magazines, the director of government regulations for the foundation, Jake McGuigan, opened his testimony with some statistics.


Mr. McGuigan told lawmakers that the state’s gun companies contributed $1.3 billion to the Connecticut economy, through their own operations and those of their suppliers.


“Each year, they get courted by other firearm-friendly states, like Idaho, Virginia, North Carolina,” Mr. McGuigan said. He later added, “It’s not an idle threat.”


The federation and Colt have declined to comment on gun-control legislation since the school killings.


“Our hearts go out to our fellow Connecticut residents who have suffered such unimaginable loss,” Colt said in a statement. “We do not believe it is appropriate to make further public statements at this very emotional time.”


Gun-control advocates in Hartford said the gun companies’ strategy was shrewd because it allowed Democratic lawmakers to oppose new regulations while proclaiming that they had not bowed to the National Rifle Association.


Michael Moss and Griff Palmer contributed reporting.



Read More..

India Ink: Protests Over Rape Turn Violent in India

Angry protests escalated into violence in India’s capital on Sunday, after thousands of people gathered to demand justice for the victim of a recent gang rape in New Delhi and improved safety for women.

Protesters flocked to the India Gate monument throughout the day, despite police attempts to deter them and a hastily enacted ban on protesting in New Delhi, where they taunted the police and attacked the car of a member of Parliament. The police, in turn, fired tear gas and water cannons, beat protesters with bamboo sticks and arrested dozens.

By late afternoon Sunday, political parties had joined the crowd, increasing the number of confrontational encounters with the police. Protesters overturned a car, and clashes turned fierce.

The crowd, made up predominantly of young people, surrounded India Gate but was prevented from marching to Rashtrapati Bhavan, the palatial home of the president. Hundreds of police officers, many in blue helmets from the country’s “Rapid Action Force,” blocked their way.

The angry crowds jostled with the police, calling them “cowardly,” “corrupt” and “inept,” as they tried to push through the cordon. “Why don’t you come and join us?” one agitated protester asked a senior police officer. “Aren’t you angry at what happened?”

Sunday marked the seventh day of protests in India after medical student was raped Dec. 16 on a moving bus by several men, the latest in a series of violent crimes against women in northern India. The victim of the gang rape suffered severe intestinal injuries after being attacked with an iron rod during the assault and was battling for her life, doctors said last week.

“We are not happy with this piecemeal, drop-in-the-ocean, inane response of the government” to concerns about women’s safety, said Albeena Shakil, 36, an activist who helped mobilize the protests. “We want some big changes,” she said. “If the administration will not do it, who will?”

Another protester, Kulsoom Rashid, 27, said she had been tear-gassed Sunday afternoon.

“This is how they are responding,” she said, seething, as she rubbed her eyes vigorously. “Hundreds of rapists are running scot-free and the entire Delhi police is standing here to stop people like me?”

Women’s and students’ groups at the protests had compiled a list of four demands: They would like the courts to fast-track about 100,000 cases involving allegations of rape; for the Indian police to pledge to register complaints of rape when they happen; for Parliament to hold a special session to pass laws on rape, sexual harassment and child abuse; and for the Delhi police commissioner to be fired for his handling of the protests.

The police tried to prevent Sunday’s demonstration from taking place. Early in the morning, nearby subway stations were closed, and the roads leading to India Gate were blocked in an attempt to deter protesters.

Protesters who had camped in the area overnight were dragged away, and more than two dozen were arrested.

The police said in a statement on Sunday morning that they had also imposed Section 144, an emergency measure in the country’s criminal procedure code aimed at preventing riots, and had outlawed large gatherings of people in New Delhi. They asked protesters to go to the Ram Lila grounds, near the northern neighborhood of Old Delhi, instead.

Still, protesters poured into the India Gate area, which faces Delhi’s grand colonial-era government seat, throughout Sunday, arriving on foot. Several said that footage of the police dragging protesters away Sunday morning had inspired them to come.

“Many students who were protesting peacefully were attacked,” said Jayati Ghosh, a professor of economics at Jawaharlal Nehru University, who had joined the protest with her daughter. “These are patriotic and respectable citizens. You cannot respond to them in this ham-handed manner,” she said.

The emergency measure remained in effect in New Delhi on Sunday afternoon, said Rajan Bhagat, a public relations officer with the Delhi police, but would not be invoked at Ram Lila. If protesters moved there, “normal life of the city won’t be disturbed,” Mr. Bhagat said.

The protest Sunday paralyzed the Edward Lutyens-designed center of Delhi, where top government officials live in grand homes set on acres of land.

The president of the governing Congress party, Sonia Gandhi, and her son, Rahul, the party’s general secretary, met a few protesters Sunday morning at Ms. Gandhi’s residence, local news stations reported. “I am with you,” Ms. Gandhi told protesters, adding that “justice will be delivered,” according to the news agency ANI.

Read More..

The ‘Teen Mom’ Twitter Proposal






Hmm. Teen mom from Teen Mom Maci Bookout was on Twitter the other day when she received a tweet from the father of her child asking her to marry him. No lie! Ryan Edwards from Teen Dad — Huh? What’s that? There’s no such show? He’s just on Teen Mom? Oh, OK — was all “Maci Bookout marry me!” And Maci was all “Ur s–t got hacked BRO! Outta ur mind haha.” And then Ryan was all “would never let that happen.” Maci asked what he was playing at and then Ryan said, omg, “It means that I want to get on one knee and tell you how much I love you.” Whoaaaa! That’s huge! Maci, marry that boy! He just proposed to you sort of maybe on Twitter! How romantic! Also you have a four-year-old child together so maybe it would be easier to be married, I dunno, for like legal reasons or something? But no. Alas. Maci responded to that saying “Twitter is not the place. Ima kill u.” So wait. If we’re going to take Ryan’s sweet Twitter proposal seriously, which we’re going to, I guess that means we have to take Maci‘s Twitter death threat seriously, too? Police, go arrest Maci. As much as it pains us to say it. Fair’s fair. Ryan, you can marry Maci while she’s in jail. Bentley, which is the name of the child that made all of this, literally all of this, possible, can come live with Ryan while Maci serves her sentence. Sad that such a sweet moment had to end so tragically. But that’s Twitter for you. [Us Weekly]


RELATED: James Franco Has a New Girl






Haha/Ew: Lindsay Lohan said she would not kiss Charlie Sheen when they were filming their scene for Scary Movie 5 because “his mouth grossed her out.” Yes. That’s actually the headline of the TMZ post: “Lindsay REFUSED to Kiss Charlie … Because His Mouth Grossed Her Out.” Man. In a thousand years, when the aliens are sifting through our bones and ashes to learn about the civilization they just annihilated, they’re going to somehow find a list of TMZ headlines and will shake their big gelatinous heads and figure they were right to wipe us out. TMZ headlines. Wooftie. But back to Lindsay, I don’t blame her. You couldn’t pay me a trillion dollars to kiss Charlie Sheen. Why not just pay me ten bucks to lick a wall at the Port Authority? Honestly. Here’s a good line from the story: “we’re told BOTH parties had to sign releases that they didn’t have cold sores.” Which, holy hell, guys. If you have to do that to film a stupid movie, maybe it’s time to pack a suitcase and more to Uruguay. Like, chuck this rotten life aside and say see you soon, Montevideo. You’d be so much happier. It’s supposed to be great down there. It’s time for a change, you guys. Don’t be another TMZ headline. [TMZ]


RELATED: Charlie Sheen and Lindsay Lohan Made Out


Naomi Campbell ate at the new Beatrice Inn on Wednesday night, hobbling in on crutches and in a leg brace after she tore a ligament or something. She ate with Vogue editor Carlyne Cerf de Dudzeele and a photographer named Steven Meisel. At a table nearby, Vera Wang, Calvin Klein, and Donna Karan were all having dinner. Excuse me?? What happened next? Did they all go to a screening of Unzipped and then to the after party, where the Spin Doctors were playing? Was everyone talking about the last MTV Top 20 and if Idalis is better than Daisy Fuentes? I mean, what? Naomi Campbell walks into a restaurant and Calvin Klein, Donna Karan, and Vera freaking Wang are eating nearby? Was Betsey Johnson the busboy? Was Cindy Crawford sweating on the line as a cook? Honestly. I didn’t realize they were still filming Prêt-à-Porter. Good grief. [Page Six]


RELATED: The 2012 Gossip Stories We Loved


Did you know that Kelly Clarkson is engaged to Reba McEntire‘s stepson? Because she is. Kelly Clarkson is engaged to Reba McEntire‘s stepson. So engaged, in fact, that Reba thinks the two might elope. Or at least she “wouldn’t be surprised” if they did. Because some big wedding wouldn’t really be Kelly’s style, apparently. Reba said as much: “That was never my deal and I don’t know that that’s Kelly’s either.” Oh, man. I wish Reba would say “that was never my deal” in a sentence about me. What a nice life Kelly Clarkson has had. Famous from a TV show and then actually famous, respectably famous. And now she gets to marry into Reba McEntire‘s family. It’s all coming together for Kelly Clarkson, guys. Just in time for the end of the world. [Us Weekly]


RELATED: In Which Taylor Swift and One Direction’s Harry Styles Get Serious


Jessica Biel has been doing a tour of Broadway recently. First she went to see Book of Mormon and afterward tweeted thusly: “Book of Mormon was too good for words . . . Except for words like amazing and best musical I’ve seen in forever and incredible!” Which is a totally boring thing to say about Book of Mormon. Here’s the skinny on that show: It’s not that good. Actually, forget the italics. It’s just not that good. Just because a Broadway musical swears and says “scrotum” a lot, does not mean it is being daring or irreverent. It’s a wan show that actually totally gives Mormonism a pass and instead averts your gaze to freaking Africa, which it just makes fun of for two hours because who’s gonna fight back on that one? Toothless and dim, that show. Entertaining, but toothless and dim. Whatever. Jessica Biel then went to go see ScarJo in Cat on a Hot Tin Roof, which good heavens I didn’t know that was in previews already. That is a nightmare. She’s playing Maggie the Cat, ScarJo is. Can you believe that? Well, believe it or not, she is. And Jessica Biel went to go see it. Tellingly, no tweets about that. Ha, not a single damn tweet about that heap. Anyway, all this playgoing has Page Six wondering if J.Biel might be hungry for a Broadway show of her own. Which would be a fine mess, wouldn’t it? Unless they do a Seventh Heaven stage play, something really serious and earnest, in which case I would walk Ms. Biel to the theater myself. But otherwise? Nope. Get thee back to the Stealth 2 set, Biel. Return to where you belong. [Page Six]


Social Media News Headlines – Yahoo! News





Title Post: The ‘Teen Mom’ Twitter Proposal
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Genetic Gamble : Drugs Aim to Make Several Types of Cancer Self-Destruct


C.J. Gunther for The New York Times


Dr. Donald Bergstrom is a cancer specialist at Sanofi, one of three companies working on a drug to restore a tendency of damaged cells to self-destruct.







For the first time ever, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers independently of where they originated — breast, prostate, liver, lung. The drugs go after an aberration involving a cancer gene fundamental to tumor growth. Many scientists see this as the beginning of a new genetic age in cancer research.




Great uncertainties remain, but such drugs could mean new treatments for rare, neglected cancers, as well as common ones. Merck, Roche and Sanofi are racing to develop their own versions of a drug they hope will restore a mechanism that normally makes badly damaged cells self-destruct and could potentially be used against half of all cancers.


No pharmaceutical company has ever conducted a major clinical trial of a drug in patients who have many different kinds of cancer, researchers and federal regulators say. “This is a taste of the future in cancer drug development,” said Dr. Otis Webb Brawley, the chief medical and scientific officer of the American Cancer Society. “I expect the organ from which the cancer came from will be less important in the future and the molecular target more important,” he added.


And this has major implications for cancer philanthropy, experts say. Advocacy groups should shift from fund-raising for particular cancers to pushing for research aimed at many kinds of cancer at once, Dr. Brawley said. John Walter, the chief executive officer of the Leukemia and Lymphoma Society, concurred, saying that by pooling forces “our strength can be leveraged.”


At the heart of this search for new cancer drugs are patients like Joe Bellino, who was a post office clerk until his cancer made him too sick to work. Seven years ago, he went into the hospital for hernia surgery, only to learn he had liposarcoma, a rare cancer of fat cells. A large tumor was wrapped around a cord that connects the testicle to the abdomen. “I was shocked,” he said in an interview this summer.


Companies have long ignored liposarcoma, seeing no market for drugs to treat a cancer that strikes so few. But it is ideal for testing Sanofi’s drug because the tumors nearly always have the exact genetic problem the drug was meant to attack — a fusion of two large proteins. If the drug works, it should bring these raging cancers to a halt. Then Sanofi would test the drug on a broad range of cancers with a similar genetic alteration. But if the drug fails against liposarcoma, Sanofi will reluctantly admit defeat.


“For us, this is a go/no-go situation,” said Laurent Debussche, a Sanofi scientist who leads the company’s research on the drug.


The genetic alteration the drug targets has tantalized researchers for decades. Normal healthy cells have a mechanism that tells them to die if their DNA is too badly damaged to repair. Cancer cells have grotesquely damaged DNA, so ordinarily they would self-destruct. A protein known as p53 that Dr. Gary Gilliland of Merck calls the cell’s angel of death normally sets things in motion. But cancer cells disable p53, either directly, with a mutation, or indirectly, by attaching the p53 protein to another cellular protein that blocks it. The dream of cancer researchers has long been to reanimate p53 in cancer cells so they will die on their own.


The p53 story began in earnest about 20 years ago. Excitement ran so high that, in 1993, Science magazine anointed it Molecule of the Year and put it on the cover. An editorial held out the possibility of “a cure of a terrible killer in the not too distant future.”


Companies began chasing a drug to restore p53 in cells where it was disabled by mutations. But while scientists know how to block genes, they have not figured out how to add or restore them. Researchers tried gene therapy, adding good copies of the p53 gene to cancer cells. That did not work.


Then, instead of going after mutated p53 genes, they went after half of cancers that used the alternative route to disable p53, blocking it by attaching it to a protein known as MDM2. When the two proteins stick together, the p53 protein no longer functions. Maybe, researchers thought, they could find a molecule to wedge itself between the two proteins and pry them apart.


The problem was that both proteins are huge and cling tightly to each other. Drug molecules are typically tiny. How could they find one that could separate these two bruisers, like a referee at a boxing match?


In 1996, researchers at Roche noticed a small pocket between the behemoths where a tiny molecule might slip in and pry them apart. It took six years, but Roche found such a molecule and named it Nutlin because the lab was in Nutley, N.J.


But Nutlins did not work as drugs because they were not absorbed into the body.


Roche, Merck and Sanofi persevered, testing thousands of molecules.


At Sanofi, the stubborn scientist leading the way, Dr. Debussche, maintained an obsession with p53 for two decades. Finally, in 2009, his team, together with Shaomeng Wang at the University of Michigan and a biotech company, Ascenta Therapeutics, found a promising compound.


The company tested the drug by pumping it each day into the stomachs of mice with sarcoma.


Read More..

Genetic Gamble : Drugs Aim to Make Several Types of Cancer Self-Destruct


C.J. Gunther for The New York Times


Dr. Donald Bergstrom is a cancer specialist at Sanofi, one of three companies working on a drug to restore a tendency of damaged cells to self-destruct.







For the first time ever, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers independently of where they originated — breast, prostate, liver, lung. The drugs go after an aberration involving a cancer gene fundamental to tumor growth. Many scientists see this as the beginning of a new genetic age in cancer research.




Great uncertainties remain, but such drugs could mean new treatments for rare, neglected cancers, as well as common ones. Merck, Roche and Sanofi are racing to develop their own versions of a drug they hope will restore a mechanism that normally makes badly damaged cells self-destruct and could potentially be used against half of all cancers.


No pharmaceutical company has ever conducted a major clinical trial of a drug in patients who have many different kinds of cancer, researchers and federal regulators say. “This is a taste of the future in cancer drug development,” said Dr. Otis Webb Brawley, the chief medical and scientific officer of the American Cancer Society. “I expect the organ from which the cancer came from will be less important in the future and the molecular target more important,” he added.


And this has major implications for cancer philanthropy, experts say. Advocacy groups should shift from fund-raising for particular cancers to pushing for research aimed at many kinds of cancer at once, Dr. Brawley said. John Walter, the chief executive officer of the Leukemia and Lymphoma Society, concurred, saying that by pooling forces “our strength can be leveraged.”


At the heart of this search for new cancer drugs are patients like Joe Bellino, who was a post office clerk until his cancer made him too sick to work. Seven years ago, he went into the hospital for hernia surgery, only to learn he had liposarcoma, a rare cancer of fat cells. A large tumor was wrapped around a cord that connects the testicle to the abdomen. “I was shocked,” he said in an interview this summer.


Companies have long ignored liposarcoma, seeing no market for drugs to treat a cancer that strikes so few. But it is ideal for testing Sanofi’s drug because the tumors nearly always have the exact genetic problem the drug was meant to attack — a fusion of two large proteins. If the drug works, it should bring these raging cancers to a halt. Then Sanofi would test the drug on a broad range of cancers with a similar genetic alteration. But if the drug fails against liposarcoma, Sanofi will reluctantly admit defeat.


“For us, this is a go/no-go situation,” said Laurent Debussche, a Sanofi scientist who leads the company’s research on the drug.


The genetic alteration the drug targets has tantalized researchers for decades. Normal healthy cells have a mechanism that tells them to die if their DNA is too badly damaged to repair. Cancer cells have grotesquely damaged DNA, so ordinarily they would self-destruct. A protein known as p53 that Dr. Gary Gilliland of Merck calls the cell’s angel of death normally sets things in motion. But cancer cells disable p53, either directly, with a mutation, or indirectly, by attaching the p53 protein to another cellular protein that blocks it. The dream of cancer researchers has long been to reanimate p53 in cancer cells so they will die on their own.


The p53 story began in earnest about 20 years ago. Excitement ran so high that, in 1993, Science magazine anointed it Molecule of the Year and put it on the cover. An editorial held out the possibility of “a cure of a terrible killer in the not too distant future.”


Companies began chasing a drug to restore p53 in cells where it was disabled by mutations. But while scientists know how to block genes, they have not figured out how to add or restore them. Researchers tried gene therapy, adding good copies of the p53 gene to cancer cells. That did not work.


Then, instead of going after mutated p53 genes, they went after half of cancers that used the alternative route to disable p53, blocking it by attaching it to a protein known as MDM2. When the two proteins stick together, the p53 protein no longer functions. Maybe, researchers thought, they could find a molecule to wedge itself between the two proteins and pry them apart.


The problem was that both proteins are huge and cling tightly to each other. Drug molecules are typically tiny. How could they find one that could separate these two bruisers, like a referee at a boxing match?


In 1996, researchers at Roche noticed a small pocket between the behemoths where a tiny molecule might slip in and pry them apart. It took six years, but Roche found such a molecule and named it Nutlin because the lab was in Nutley, N.J.


But Nutlins did not work as drugs because they were not absorbed into the body.


Roche, Merck and Sanofi persevered, testing thousands of molecules.


At Sanofi, the stubborn scientist leading the way, Dr. Debussche, maintained an obsession with p53 for two decades. Finally, in 2009, his team, together with Shaomeng Wang at the University of Michigan and a biotech company, Ascenta Therapeutics, found a promising compound.


The company tested the drug by pumping it each day into the stomachs of mice with sarcoma.


Read More..